My bookmarksSign up free

Commission Implementing Decision (EU) 2026/378 Article 2

Commission Implementing Decision (EU) 2026/378 Article 2

Article 2

Treated articles treated with or intentionally incorporating etofenprox for use in biocidal products of product-types 8 and 18 shall no longer be placed on the market as from 11 September 2026.

Read the full instrument →

Other provisions in Commission Implementing Decision (EU) 2026/378

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 2 of Commission Implementing Decision (EU) 2026/378 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next